Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

The role of vascular endothelial growth factor gene as the genetic marker of atherothrombotic disorders and in the gene therapy of coronary artery disease.

Cardiovascular & hematological agents in medicinal chemistry - 1 Jan 2010

Petrovic Daniel

Abstract excerpt

Many human diseases are characterized by vasculature disorders. Out of the many players in the angiogenic network, the vascular endothelial growth genes are by far the best characterized. The vascular endothelial growth factor (VEGF) has been implicated in the pathogenesis of coronary artery disease (CAD) and in its complication, the acute myocardial infarction (AMI). Several common polymorphisms in the promoter...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Clinical Trials as Topic
Share to Coronary Artery Disease

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Share to CAD gene

Share to Genetic Markers

Share to Genetic Therapy

Share to Myocardial Infarction

Share to Polymorphism, Single Nucleotide

Share to Vascular Endothelial Growth Factor A

Source

Identifiers

PMID: 20210775
DOI: 10.2174/187152510790796183

Genes

CAD

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence. Graph snapshot: 2026-09-29.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

The role of vascular endothelial growth factor gene as the genetic marker of atherothrombotic disorders and in the gene therapy of coronary artery disease.PMID 20210775Read ↗

Further evidence for the contribution of the vascular endothelial growth factor gene in coronary artery disease susceptibility.Semantic proximity Read ↗

Association of VEGF gene polymorphisms with the development of heart failure in patients after myocardial infarction.Semantic proximity Read ↗

Variation in the vascular endothelial growth factor gene, carotid intima-media thickness and the risk of acute myocardial infarction.Semantic proximity Read ↗

Genetic variants of VEGFR-1 gene promoter in acute myocardial infarction.Semantic proximity Read ↗

Association of genetic polymorphisms in vascular endothelial growth factor with susceptibility to coronary artery disease: a meta-analysis.Semantic proximity Read ↗

Genetic variations in vascular endothelial growth factor and endothelial nitric oxide synthase and their contributions to human disease.Semantic proximity Read ↗

Genetic polymorphisms in VEGFA and VEGFR2 genes associated with coronary heart disease susceptibility and severity.Semantic proximity Read ↗

Evaluation of VEGFA gene variants for possible roles in cerebral infarction diseasesSemantic proximity Read ↗

Vascular endothelial growth factor gene polymorphisms in susceptibility to coronary artery disease.Semantic proximity Read ↗

Vascular endothelial growth factor-A promoter polymorphisms, circulating VEGF-A and survival in acute coronary syndromes.Semantic proximity Read ↗

Vascular endothelial growth factor A polymorphisms are associated with increased risk of coronary heart disease: a meta-analysis.Semantic proximity Read ↗

Vascular endothelial growth factor polymorphisms and coronary artery disease: a systemic review and meta-analysis.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.